Fourier Intelligence & Thor Assistive Technologies will participate in Naidex/Neuro Convention 2023, showcasing advancing technologies in medical robotics within the market in the UK.
Birmingham, United Kingdom, 14 March – Fourier Intelligence is pleased to announce its participation at Naidex/Neuro Convention 2023 this 22nd and 23rd March at the NEC, Birmingham. The event is in conjunction with Naidex’s golden jubilee celebration of the disability community.
Known as a leading provider of innovative rehabilitation technology solutions, Fourier Intelligence will be joined by its partner, Thor Assistive Technologies, where the team will be showcasing RehabHub™ and providing first-hand experiences of the currently available medical and community-based devices.
As a health technology group, Fourier Intelligence strives towards promoting the adoption of robotics technologies within the various markets in the United Kingdom by allowing hands-on advanced robotics rehabilitation technology, which would benefit healthcare professionals and the disability community. Besides that, we also aim to provide easy and accessible solutions to help improve the quality of life and care within the disabled community.
“We are thrilled to be exhibiting at Naidex, the UK’s most prestigious event for disability and independent living. As a global technology company committed to enhancing human ability through robotics and AI, we are excited to showcase our latest innovations and solutions that empower people with disabilities to lead more independent and fulfilling lives. We look forward to connecting with like-minded individuals and organisations and contributing to advancing assistive technology for the benefit of all,” shared Zen Koh, Co-Founder and Global CEO of Fourier Intelligence.
The Naidex/Neuro Convention event is open to all; however, attendees must pre-register online via the event’s website, https://www.naidex.co.uk/outbound-utm. Fourier Intelligence invites all visitors and interested parties to booth number, N-68. Visitors can directly browse and purchase Fourier Intelligence’s available home devices for individual needs.
Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
Fourier Intelligence achieves another milestone through its MOU signing with Flinders University towards advancing technologies in medical robotics.
Adelaide, South Australia, 2nd March 2023 – Fourier Intelligence signed a Memorandum of Understanding (MOU) with Flinders University in Adelaide, South Australia, signifying the commencement of a partnership towards advancing medical technologies.
Both parties agree on strengthening, promoting, and developing academic, cultural, and research cooperation.
The partnership between Fourier Intelligence and Flinders University can positively impact and improve the lives of people that developed a gait impairment following a stroke. This is made possible through the ability to interface and test the technology available with the ExoMotus™ trial and validation. Additionally, there will be many opportunities for undergraduate and postgraduate students at Flinders University to have first-hand experiences using Fourier Intelligence’s technology before entering the workforce.
Fourier Intelligence’s Co-Founder and Global CEO, Zen Koh; Owen Teoh, General Manager and Taya Hamilton, Clinical Application and Research Consultant (Oceania Region), commemorated this momentous occasion through a virtual signing ceremony alongside the team from Flinders University, Dr David Hobbs, Researcher & Academic, College of Science and Engineering, Professor Karen Reynolds, Director of the Medical Device Research Institute and Simon Brennan, Chief Research Development Officer, Flinders University’s Research, Development & Support.
Zen Koh shared the importance and significance of this collaboration, adding that ensuring continual growth, sustenance, and innovation is crucial. “Our partnership helps us grow in possibilities towards collaborating in meaningful technologies, clinical protocols, and clinical usage, which is very close to our hearts. By joining forces, we aim to achieve what is most vital, making technologies more accessible to those who require it.”
Simon Brennan adds that Flinders have increased their research performance over the last four years, which is considered remarkable by Australian standards. “We’ve achieved that by playing towards our strengths, largely the medical and health research and partnership areas. Therefore, we’re excited about this opportunity to journey together towards making this possible.”
“The ExoMotus™ exoskeleton is the perfect platform for our current project to assess the feasibility and potential of a novel robotic gait bio-prosthesis for people with severe gait impairment post-stroke. Flinders University is proud to partner with Fourier Intelligence and to plug into its global network of excellence and capability,” added Dr. David Hobbs.
In partnership with their South Australian colleagues and through MRFF funding, they aim to demonstrate that their novel sensor and controller provide more intuitive access and better therapeutic gait outcomes for post-stroke survivors.
About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
About Flinders University and Flinders University Capacity
Research and creative endeavour have been at the core of Flinders’ identity since its inception. Over recent years, their research activity has grown dramatically, with an exciting increase in capacity and impact. Externally funded research activity has more than doubled over the past three years. Through research and the translation of that research, they are generating new knowledge and capabilities that are improving lives and the world around us.
Flinders University is part of Australia’s Innovative Research Universities network and leader in Biomedical and Rehabilitation Engineering. Flinders has been teaching and researching Biomedical Engineering for 30 years, producing graduates who have gone on to be awarded prestigious awards such as Churchill Fellowships, Sir General John Monash Scholarships, Fulbright Scholarships, and national awards for innovative devices. Similarly, the Academic teaching staff have received multiple awards, including the Australian Professional Engineer of the Year, the South Australian Scientist of the Year, a team award from the Australian Learning and Teaching Council recognising teaching excellence within the Biomedical Engineering program, and having multiple staff named as being among the most influential engineers in Australia.
Their Biomedical Engineering activities are based at Australia’s first-ever innovation district, the Tonsley Innovation District. This is where one of Flinders University’s flagship Institutes, the Medical Device Research Institute, is based, a cross-discipline, whole of university Institute at the forefront of medical device research and development. It fosters a thriving community of businesses, organisations, start-ups, and tertiary education, with a critical focus on health and medical devices.
A specific capability and focus are Rehabilitation Engineering and Assistive Technologies (RE and AT), which have been a part of Flinders University’s DNA since 1997 when the first industry-based tertiary education topic in this niche area was taught in Australia.
The MDRI has specific laboratories to support its RE and AT activities, including a 3D rehabilitation and motion analysis laboratory, to test and trial new technological advances such as advanced robotic exoskeletons. Additionally, one of Flinders University’s most famous robotics alums is Dr Rodney Brooks, and robotics is a growing area of research and industrial collaboration through co-bot technologies and applications.
Singapore, 22 February – Fourier Intelligence is excited to announce that its Co-Founder and Global CEO, Zen Koh, has been recognised as one of the Top 10 Inspiring Healthcare Entrepreneurs to Watch in 2023 by Entrepreneur Asia Pacific. This prestigious honour is a testament to Zen’s exceptional leadership, vision, and contributions to the healthcare industry. We at Fourier Intelligence are proud to have Zen at the helm and congratulate him on this well-deserved recognition.
Fourier Intelligence, a leading provider of innovative rehabilitation technology solutions, has announced that Zen Koh, a highly experienced and respected industry veteran, has been overseeing the company’s neurorehabilitation robotics program since he joined the team in 2018. Before joining Fourier Intelligence, Zen spent over a decade working with a Swiss-based company, where he developed extensive expertise in brain injuries and neuro-disorders.
The prestigious Top 10 Inspiring Healthcare Entrepreneurs to Watch in 2023 award is bestowed upon entrepreneurs who display excellence and innovative qualities in their field. This recognition showcases Fourier Intelligence’s commitment to improving patient care and its dedication to revolutionising the healthcare industry with its cutting-edge technology. Fourier Intelligence has achieved significant success quickly, and this recent accolade further confirms that the group understands what the healthcare industry requires in the unique post-pandemic market.
Zen Koh, Fourier Intelligence
“This prestigious honour deeply humbles me. It is a testament to Fourier Intelligence’s commitment to advancing the healthcare industry through collaboration with clinical research and technology development partners. This recognition further reinforces our dedication to achieving our vision of creating a more consolidated and standardised healthcare industry that benefits our industry and the wider community. We look forward to continuing our journey towards this goal with our valued partners.”
As the Co-Founder and Global CEO of Fourier Intelligence, Zen has been instrumental in ensuring that the company’s breakthrough technology meets the needs of patients across all age groups. His vast experience and in-depth industry knowledge have been invaluable in guiding the company towards achieving its mission of revolutionising the healthcare industry with innovative rehabilitation technology solutions.
Under Zen’s leadership, Fourier Intelligence has made significant strides in the field of neurorehabilitation robotics, and the company is well-positioned to continue its success in the future. Fourier Intelligence remains committed to delivering the highest quality patient care through its state-of-the-art technology. Zen’s contributions to the company’s success have been instrumental in achieving this goal.
Upon being recognised as one of Entrepreneur Asia Pacific’s Top 10 Inspiring Healthcare Entrepreneurs to Watch in 2023, Zen Koh, Co-Founder and Global CEO of Fourier Intelligence, expressed his gratitude and dedication to the company’s mission. When asked about this accomplishment, he remarked, “Fourier is dedicated to providing cutting-edge, high-quality technologies to advance clinical rehabilitation to provide more comprehensive and user-centred solutions. It’s an honour to be recognised alongside some of today’s most successful entrepreneurs.”
Based in Singapore, Zen holds multiple leadership positions, including the incoming president of the International Industry Society for Advanced Rehabilitation Technology (IISART), General Chair for RehabWeek 2023, co-founder and Executive Director of the Swiss-based MotusAcademy Association, and Managing Editor of the Journal of Rehabilitation Methods and Technologies (JRMT).
Zen’s extensive experience in the industry has been significant in driving Fourier Intelligence’s growth and success. His diverse skillset and leadership positions highlight his commitment to advancing the rehabilitation technology field and improving patient care.
As a Co-Founder and Global CEO of Fourier Intelligence, Zen’s unwavering dedication to delivering high-quality, innovative rehabilitation technology has led to the company’s reputation as a leader in the field. Zen’s continued involvement in industry organisations and initiatives further cements his position as a respected thought leader and advocate for patient-centred care.
Fourier Intelligence remains committed to providing high-quality patient care through innovative rehabilitation technology solutions. Zen’s continued leadership and involvement in industry organisations and initiatives will be critical to the company’s continued growth and success.
About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
For investor and media inquiries, please contact:
Sarah LIM Assistant Director, Support Services Fourier Intelligence Phone: +65 6911 6651 Email: marketing.globalhq@fourierintelligence.com
Riyadh, Saudi Arabia, 21 February 2023 – Fourier Intelligence, the leading AI rehabilitation solutions provider, and John Hopkins Aramco Healthcare, a subsidiary of Saudi Aramco and one of the leading healthcare providers in the Middle East, announced today the signing of a memorandum of understanding (MOU) at the second LEAP event in Riyadh.
The MOU outlines the collaboration between the two organisations to explore opportunities to integrate Fourier Intelligence’s cutting-edge AI technology into physical rehabilitation treatments at John Hopkins Aramco Healthcare facilities.
This collaboration will potentially allow John Hopkins Aramco Healthcare patients to benefit from Fourier Intelligence’s AI-powered rehabilitation technology, significantly enhancing the rehabilitation process and speeding up recovery. The technology will also allow real-time tracking and monitoring of patients’ progress and make data-driven recommendations for further treatment.
“We are thrilled to collaborate with John Hopkins Aramco Healthcare to bring our cutting-edge technology to the Middle East,” said Zhi Kang TAI, Commercial Director of Fourier Intelligence. “Our AI-powered rehabilitation solutions are changing the game in the physical rehabilitation industry. This collaboration will allow us to provide access to our innovative technology to more patients in need.”
“We are proud to collaborate with Fourier Intelligence to bring their innovative AI technology to our patients,” said Lamia Alzayer, Sr. Director, Specialised Therapy & Clinical Services of John Hopkins Aramco Healthcare. “This collaboration represents our commitment to providing the highest quality of care and utilising cutting-edge technology to improve patient outcomes.”
The MOU signing ceremony by Zhi Kang TAI, Commercial Director of Fourier Intelligence and Lamia Alzayer, Sr Director, Specialised Therapy & Clinical Services of John Hopkins Aramco Healthcare
The MOU signing ceremony was attended by senior executives from both organisations at the second edition of LEAP, attended by over 100,000 technology innovators and experts worldwide.
About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
About John Hopkins Aramco Healthcare:
Johns Hopkins Aramco Healthcare Company (JHAH) is the result of a joint venture between Saudi Aramco, a world leader in energy, and Johns Hopkins Medicine, one of the world’s leading academic health systems. This healthcare organisation is designed to drive and enhance the community’s well-being in an environment of growth and learning by providing innovative, integrated, patient-centred care to Saudi Aramco’s employees and healthcare beneficiaries.
Fourier Intelligence and Bond University embark on their journey to showcasing advancing technologies in medical robotics through significant steps.
Gold Coast, Australia, 15 February 2023 – Fourier Intelligence, a leading provider of rehabilitation solutions, and Bond University, Australia’s leading independent, not-for-profit university, signed a Memorandum of Understanding (MoU), marking the commencement of a significant partnership to optimise further and develop the implementation, integration, and adoption of rehabilitation technology.
Both parties agree on strengthening, promoting, and developing academic, cultural, and research cooperation.
Fourier Intelligence’s Co-Founder and Global CEO, Zen Koh; Dr Chen-Onn Leong, Manager of Scientific Research; Taya Hamilton, Clinical Consultant, commemorated this momentous occasion through a virtual ceremony alongside representatives from Bond University; Professor Wayne Hing, Head of Physiotherapy, Assistant Professor Philip Abery and Assistant Professor Elisa Canetti from Bond’s Faculty of Health Sciences & Medicine; and Andrew Pearce, Managing Director of AIMedical.
The collaboration between both parties hopes to bring advancements in rehabilitation technology to individuals across all stages of rehabilitation, ensuring access to the care and technology they need. The emergence of a new gait lab and upcoming research project exploring the integration of exoskeleton technology into the home and community settings at Bond University brings this possibility a step closer.
Zen Koh shared the importance and significance of this collaboration with Bond University, adding that ensuring continual growth, sustenance, and innovation is crucial. “We’re taking another step forward in bringing more partners and collaborators to journey with us from the clinical research and technology development front through partnership and bring us much closer to achieving our dreams of making the industry more consolidated and standardised, benefiting both our clinicians and patients.”
Professor Hing adds, “We’re excited for the growth opportunities based around the concept of rehabilitation returning to the community and being able to utilise medical robotics at home. Bond University’s new gait lab will allow laboratory-based research in our facilities. It ideally strategically transforms our approach from the lab into the homes and communities.”
About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
About Bond University
Bond University is Australia’s leading independent, not-for-profit university, dedicated to a deliberately different, personalised approach to education. Bond’s Faculty of Health Sciences and Medicine is recognised for the excellence of its education and research in medical, health and sports sciences. The faculty is a national leader in teaching and producing work-ready graduates with the leadership skills to improve local, national, and global health and well-being. Bond offers a personalised education experience, and for the past sixteen consecutive years, the university has ranked No. 1 in Australia for student experience.
For investor and media inquiries, please contact: Sarah Lim, Assistant Director, Support Services at Fourier Intelligence, Fourier Intelligence Phone: +65 6911 6651 Email: marketing.globalhq@fourierintelligence.com
Switzerland, 25th January 2023 – Fourier’s Global Standard Development Lead, Burkhard Zimmermann, has been elected Technical Project Lead for IEC SC62D JWG 36 (RACA Robot). Based in Switzerland, he will focus on advancing global standards implementation in medical robotics for rehabilitation.
Burkhard is the founding member of the International Industry Society in Advanced Rehabilitation Technology (IISART), an organisation dedicated to advancing modern healthcare technology to benefit the patient and the profession. Burkhard’s new role as Technical Project Lead for RACA Robot is vital for Fourier Intelligence’s positive support in international standards and other publications to support safety and performance for medical equipment and software systems.
Burkhard Zimmermann
JWG36 is an esteemed committee dedicated to continuously improving the standards applicable to the general requirements for basic safety and essential performance of medical robots for rehabilitation, compensation or alleviation of disease, injury or disability.
“Medical robotics have come a long way from its origins. There have been leaps and bounds in terms of the technology available for a wide range of procedures, increasing efficiencies, productivity, safety and quality,” said Zen Koh, incoming President of IISART, Co-Founder and Global CEO of Fourier Intelligence.
“As standards emerge and evolve to ensure the safety and performance of these cutting-edge products, it is our responsibility as innovation leaders to stay current on the requirements in ensuring compliance when bringing such devices into the market. Burkhard’s new role at IEC will support Fourier’s efforts in delivering top-quality products that are safe and efficient.”
About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
For investor and media inquiries, please contact: Sarah Lim, Assistant Director, Support Services at Fourier Intelligence, Fourier Intelligence Phone: +65 6911 6651 Email: marketing.globalhq@fourierintelligence.com
Fourier Intelligence is now a member of Electrosuisse, a global trade association for electrical, energy, and information technology
SWITZERLAND, 21 December 2022 – Leading health technology group Fourier Intelligence is happy to announce joining Electrosuisse as a member. Electrosuisse has focused on promoting safe, economic, and environmentally friendly electricity generation and usage for the past 130 years.
Founded in 1889, Electrosuisse has become a global trade association for electrical, energy, information, and communication technology. As a specialist organisation with over 2000 members, it has also played a crucial role in disseminating knowledge and interest groups within the field with information on international standardisation and certification bodies.
Electrosuisse is a member of the International Electrotechnical Commission (IEC) and represents Switzerland. The organisation offers training, advice, inspection, testing and certification to ensure environmental governance is met.
As a health technology group, Fourier Intelligence is known to have an extensive portfolio of solutions to offer. Developing such advanced technology takes considerable energy and requires plenty of testing for medical devices. Being a member of Electrosuisse further signifies its mission to promote economical and safe devices to its clients and partners.
“We are pleased and look forward to being a part of Electrosuisse. As the standardisation and certification of each country evolve, it is crucial to stay connected to support one another in this matter,” mentioned Zen Koh, Co-Founder and Global CEO of Fourier Intelligence Group.
“The association’s vision aligns with Fourier’s goal of promoting safe and economic health technology to our network. We believe that together with the vast network of Electrosuisse, we can widely influence and promote safer technology by contributing our expertise to international standardisation activities.”
About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
For investor and media inquiries, please contact: Sarah Lim, Assistant Director, Support Services at Fourier Intelligence, Fourier Intelligence Phone: +65 6911 6651 Email: marketing.globalhq@fourierintelligence.com
Fourier Intelligence signs a Memorandum of Understanding with United Kingdom distributor and sales partner Thor Assistive Technologies to extend the reach of products to the Europe Market
UNITED KINGDOM, 30 November 2022 – Fourier Intelligence and Thor Assistive Technologies signed a Memorandum of Understanding (MOU) witnessed by the British Consulate online via Zoom on 23 November 2022 at UK MedTech Forum in China International Medical Equipment Fair (CMEF).
The CMEF represents an online international medical equipment exhibition to connect global licensed medical equipment distributors, resellers, manufacturers, health professionals, and agencies. The event started with Matt Moddy, British Consul-General in Guangzhou, providing the opening remarks, followed by various speeches by Dr. Linda Magee (Health Innovation and NGS Specialist, Department for International Trade) and Paul Benton (Managing director International, Association of British Health Industries).
The tech giant Fourier Intelligence represents one of the four companies selected to participate in the United Kingdom (UK) Med Tech Forum MOU signing to represent the partnership between China and the UK.
The MoU Signing Ceremony then began alongside the DIT Digital Platform Launching. The signatory included Zen Koh, Co-Founder and Global CEO of Fourier Intelligence, and Neil Shorthouse, Finance Director of Thor Assistive Technologies. Furthermore, the signing event included witnesses such as Owen Teoh, General Manager of Fourier Intelligence, Chris Sloan, Company Director of Thor Assistive Technologies, and the British Embassy and Consulate SLTs.
The partnership allows Fourier Intelligence to distribute in the UK, spreading their rehabilitation solutions globally and leveraging the European research and market. At the same time, Thor Assistive Technologies gains to provide a broader range of technology solutions to the UK health sector, making their rehabilitation solutions more diverse and comprehensive to cater to public needs.
About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
For investor and media inquiries, please contact: Sarah Lim, Assistant Director, Support Services at Fourier Intelligence, Fourier Intelligence Phone: +65 6911 6651 Email: marketing.globalhq@fourierintelligence.com
Melbourne, 24th November 2022 – The Institute of Electrical and Electronics Engineers (IEEE) has just announced its 2023 Fellows. Professor Ying Tan, Co-Director of the University of Melbourne-Fourier Intelligence Robotics Joint Laboratory, was amongst 319 scientists that were selected. This recognition is given to eminent scholars and scientists who have made substantial contributions to research, teaching, or scholarly efforts. The award recognises Professor Ying Tan’s achievements in rehabilitation robotics.
The IEEE is the world’s largest international professional association for advancing technology for humanity’s benefit. It has remained an essential organisation to technical professionals universally and is recognised for the contributions of technology and improving global conditions. Since its inception in 1963, it has gained over 409,000 members across 160 countries.
Professor Ying Tan obtained the highest grade of membership – the IEEE Fellow. This demonstrates a distinction for the profession that required peers’ nominations and approval by the IEEE Board of Directors. An average of 300 members are selected each year, and the number of elected members shall not exceed 1% of the current year’s total number of IEEE members.
In 2004, Professor Ying Tan joined the Department of Electrical and Electronic Engineering at the University of Melbourne. She has since demonstrated significant contributions to the advancement of technology, leading to over 100 published papers in journals and conferences and attracting more than 7 million Australian dollars in research funding.
On top of being the IEEE Fellow, Professor Ying Tan was awarded the Australian Postdoctoral Fellow and Future Fellow in 2006 and 2014, respectively, by the Australian Research Council. Since 2018, she has been a co-director of the successful industry-academic joint lab with Softbank-backed Fourier Intelligence in advancing rehabilitation robotics technology.
Figure 1: Professor Ying Tan is working with Dr Vincent Crocher on the first prototype of the ArmMotus™ EMU
Her current work with Fourier Intelligence focuses on technologies to assist with movement impairments, especially for those with neurological conditions. Her team in Melbourne carries out fundamental and translational research for rehabilitation robotics. The ArmMotus™ EMU was a successful commercialisation project from the lab.
Figure 2: The finalised ArmMotus™ EMU from the University of Melbourne-Fourier Robotics Joint Laboratory
“We are pleased to congratulate Professor Ying Tan on her recent appointment as a Fellow by the IEEE,” said Zen Koh, Co-Founder and Global CEO of Fourier Intelligence, Co-Director of the University of Melbourne-Fourier Robotics Joint Laboratory. “Ying has led, as co-director, research that resulted in successful technology transfer. The award-winning ArmMotus™ EMU is just one such example. She is a well-deserving recipient for her impactful contributions to rehabilitation robotics, and we look forward to working with her in future joint efforts.”
About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
For investor and media inquiries, please contact: Sarah Lim, Assistant Director, Support Services at Fourier Intelligence, Fourier Intelligence Phone: +65 6911 6651 Email: marketing.globalhq@fourierintelligence.com
Fourier Intelligence showcases award-winning technology at International MEDICA-TradeFair 2022 in Düsseldorf, Germany
DÜSSELDORF, GERMANY, 18 November 2022 – Fourier Intelligence makes its mark in Germany as part of the several thousand exhibition booths from more than 50 countries at MEDICA-TradeFair 2022, from 14 to 17 November 2022. For more than 40 years, MEDICA-TradeFair has been purposed to showcase the leading innovations and businesses in medical technology, products, devices, and instruments. The event was attended by thousands of national and international leaders, health professionals and decision-makers.
As one of the forerunners in rehabilitation technology, Fourier Intelligence was part of the physiotherapy and orthopaedic technology exhibition hall showcasing various award-winning rehabilitation technology and solutions. In addition, the technology unicorn conducted daily demos of some of its featured products, such as the ArmMotus™ EMU and M2 Pro, highlighting its fun, immersive, interactive gaming software. It also doubles up as group therapy through its Wi-Fi connection, allowing multiple patients to play against one another in real time.
The fair also provided the rehabilitation robotics leaders with a platform to promote RehabHub™, which represents a one-stop rehabilitation solution that gives a variety of rehabilitation robotics with online interconnectivity.
As forerunners in rehabilitation technology, it’s no surprise that Fourier Intelligence technology solutions represent MEDICA-TradeFair 2022’s theme of “where healthcare is going” by increasing the efficiency of rehabilitation, reducing the strain of health professionals, while also making rehabilitation enjoyable for its users.
About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
For investor and media inquiries, please contact: Sarah Lim, Assistant Director, Support Services at Fourier Intelligence, Fourier Intelligence Phone: +65 6911 6651 Email: marketing.globalhq@fourierintelligence.com
Cart is empty 
